Chronic cough, defined as a cough lasting more than eight weeks, poses a significant challenge to healthcare professionals. Its multifactorial etiology, combined with the subjective nature of symptoms, often complicates diagnosis and treatment.
Common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) secondary to rhinosinus conditions. However, non-acid reflux, non-asthmatic eosinophilic bronchitis, and atypical presentations of lung disease should also be considered. A comprehensive patient history, physical examination, and targeted diagnostic testing are crucial in identifying the underlying cause.
Management of chronic cough should be tailored to the identified cause. Empiric treatment for GERD, UACS, and asthma may be initiated in the absence of definitive diagnostic testing. However, refractory cases require further investigation. Non-pharmacological interventions, including lifestyle modifications and speech therapy, have proven beneficial in certain cases. Pharmacological treatments, such as inhaled corticosteroids, proton pump inhibitors, and gabapentin, have demonstrated efficacy in randomized controlled trials.
Novel therapies targeting neuronal hypersensitivity, a common feature in chronic cough, are under investigation. P2X3 receptor antagonists, such as gefapixant, have shown promising results in phase II clinical trials, offering a potential new avenue for treatment.
Chronic cough management requires a comprehensive, patient-centered approach. Understanding the multifactorial etiology and adopting a systematic diagnostic and therapeutic strategy can improve patient outcomes. Emerging therapies targeting neuronal hypersensitivity offer exciting future possibilities. Continued research and clinical collaboration are paramount in further unraveling the complexities of this common, yet challenging, clinical entity.
1.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
2.
In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.
3.
Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes
4.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
5.
Cancer screening rates down among American adults
1.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
2.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
3.
A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
2.
From Guidelines to Practice: Hematology
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation